The link between epigenetics, pain sensitivity and chronic pain
Authors:
- 26 September 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 22 (4) , 664-666
Abstract
Increasing evidence suggests an association between gene expression and clinical pain. Epigenetic modifications are the main modulators of gene expression or protein translation in response to environmental stimuli and pathophysiological conditions. Preclinical and clinical studies indicate that epigenetic modifications could also impact the development of pain, the transition from acute to chronic pain, and the maintenance hereof.Keywords
This publication has 24 references indexed in Scilit:
- MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditionsNeurobiology of Disease, 2014
- Differential methylation of the TRPA1 promoter in pain sensitivityNature Communications, 2014
- Epigenetics and the Transition from Acute to Chronic PainPain Medicine, 2012
- Mechanisms of Chronic Pain in OsteoarthritisCurrent Rheumatology Reports, 2012
- Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injuryBrain Research, 2011
- Epigenetics in pain and analgesia: An imminent research fieldEuropean journal of pain, 2011
- Epigenetics in cancerCarcinogenesis, 2009
- Epigenetics: Definition, Mechanisms and Clinical PerspectiveSeminars in Reproductive Medicine, 2009
- Increased OPRM1 DNA Methylation in Lymphocytes of Methadone-Maintained Former Heroin AddictsNeuropsychopharmacology, 2008
- Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference valuesPain, 2006